Human pathogenic RNA viruses establish noncompeting lineages by occupying independent niches.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
07 06 2022
Historique:
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 3 6 2022
Statut: ppublish

Résumé

Many pathogenic viruses are endemic among human populations and can cause a broad variety of diseases, some potentially leading to devastating pandemics. How virus populations maintain diversity and what selective pressures drive population turnover is not thoroughly understood. We conducted a large-scale phylodynamic analysis of 27 human pathogenic RNA viruses spanning diverse life history traits, in search of unifying trends that shape virus evolution. For most virus species, we identify multiple, cocirculating lineages with low turnover rates. These lineages appear to be largely noncompeting and likely occupy semiindependent epidemiological niches that are not regionally or seasonally defined. Typically, intralineage mutational signatures are similar to interlineage signatures. The principal exception are members of the family Picornaviridae, for which mutations in capsid protein genes are primarily lineage defining. Interlineage turnover is slower than expected under a neutral model, whereas intralineage turnover is faster than the neutral expectation, further supporting the existence of independent niches. The persistence of virus lineages appears to stem from limited outbreaks within small communities, so that only a small fraction of the global susceptible population is infected at any time. As disparate communities become increasingly connected through globalization, interaction and competition between lineages might increase as well, which could result in changing selective pressures and increased diversification and/or pathogenicity. Thus, in addition to zoonotic events, ongoing surveillance of familiar, endemic viruses appears to merit global attention with respect to the prevention or mitigation of future pandemics.

Identifiants

pubmed: 35639694
doi: 10.1073/pnas.2121335119
pmc: PMC9191635
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2121335119

Références

Viruses. 2021 May 14;13(5):
pubmed: 34069006
mBio. 2018 Nov 27;9(6):
pubmed: 30482837
Mol Biol Evol. 2007 Aug;24(8):1586-91
pubmed: 17483113
Nat Rev Microbiol. 2017 Mar;15(3):183-192
pubmed: 28090077
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Commun. 2014 Jun 16;5:4084
pubmed: 24933611
FEBS Lett. 2003 Jun 19;545(2-3):177-82
pubmed: 12804771
Nat Rev Genet. 2016 Oct 14;17(11):704-714
pubmed: 27739533
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
J Virol. 2008 Jan;82(2):596-601
pubmed: 17942553
PLoS Comput Biol. 2013;9(3):e1002947
pubmed: 23555203
Virus Genes. 2015 Apr;50(2):177-88
pubmed: 25537948
Viruses. 2019 Aug 29;11(9):
pubmed: 31470643
Science. 2015 Sep 4;349(6252):1259504
pubmed: 26339035
Jpn J Genet. 1991 Aug;66(4):367-86
pubmed: 1954033
J Hepatol. 2021 Aug;75(2):311-323
pubmed: 33845061
Viruses. 2016 Jun 11;8(6):
pubmed: 27294951
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292871
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Trends Genet. 2002 Sep;18(9):486
pubmed: 12175810
Genetics. 2018 Dec;210(4):1151-1162
pubmed: 30523166
Mol Biol Evol. 2011 Feb;28(2):873-7
pubmed: 20705907
Trends Genet. 2020 Apr;36(4):243-258
pubmed: 31954511
Annu Rev Virol. 2018 Sep 29;5(1):69-92
pubmed: 30048219
J Virol. 2003 Oct;77(20):11296-8
pubmed: 14512579
Science. 2006 Dec 22;314(5807):1898-903
pubmed: 17185596
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
Science. 2017 Mar 24;355(6331):1302-1306
pubmed: 28336667
J Virol. 2015 Oct 28;90(2):862-72
pubmed: 26512086
Viruses. 2021 Mar 08;13(3):
pubmed: 33800518
Biol Direct. 2006 Oct 26;1:34
pubmed: 17067369
Biomed Res Int. 2015;2015:376230
pubmed: 25866777
Science. 2004 Jan 16;303(5656):327-32
pubmed: 14726583
Nat Rev Microbiol. 2018 Feb 12;16(3):125-142
pubmed: 29430005
Nat Rev Dis Primers. 2020 Feb 20;6(1):13
pubmed: 32080199
Heredity (Edinb). 2016 Oct;117(4):193-206
pubmed: 27353047
Nat Rev Dis Primers. 2016 Jul 14;2:16049
pubmed: 27411684
Trends Ecol Evol. 2014 Nov;29(11):594-9
pubmed: 25237032
Mol Biol Evol. 2011 Dec;28(12):3355-65
pubmed: 21705379
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S19-24
pubmed: 14730266
Annu Rev Virol. 2020 Sep 29;7(1):83-101
pubmed: 32196426
J Clin Virol. 2013 Nov;58(3):541-7
pubmed: 24041471
Viruses. 2021 Feb 09;13(2):
pubmed: 33572257
Nat Rev Microbiol. 2019 May;17(5):321-328
pubmed: 30518814
Virulence. 2017 Oct 3;8(7):1450-1456
pubmed: 28723277
PLoS Pathog. 2007 May 18;3(5):e75
pubmed: 17511518
Virus Res. 2019 May;265:1-9
pubmed: 30831177
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19009-19018
pubmed: 31484772
Am J Trop Med Hyg. 2017 Mar;96(3):727-734
pubmed: 28044043
Can J Infect Dis Med Microbiol. 2014 Jul;25(4):186-8
pubmed: 25285119
Stud Hist Philos Biol Biomed Sci. 2020 Feb;79:101226
pubmed: 31882202
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Elife. 2019 Sep 18;8:
pubmed: 31532393
Vaccines (Basel). 2020 Aug 12;8(3):
pubmed: 32806696
Genetics. 2000 Jul;155(3):1429-37
pubmed: 10880500
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Curr Opin Virol. 2018 Feb;28:20-25
pubmed: 29107838
Pathogens. 2019 Jul 29;8(3):
pubmed: 31362404
J Virol. 1999 Mar;73(3):1941-8
pubmed: 9971773
Nucleic Acids Res. 2017 Jan 4;45(D1):D482-D490
pubmed: 27899678
Nat Rev Microbiol. 2007 Oct;5(10):801-12
pubmed: 17853907
PLoS Genet. 2008 Dec;4(12):e1000304
pubmed: 19081788
Viral Immunol. 2018 Mar;31(2):174-183
pubmed: 29373086
BMC Evol Biol. 2011 Jul 25;11:220
pubmed: 21787390
Mol Biol Evol. 2001 Dec;18(12):2298-305
pubmed: 11719579
Am Nat. 2013 Oct;182(4):494-513
pubmed: 24021402
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7879-7887
pubmed: 32209672
F1000Res. 2021 Jun 4;10:447
pubmed: 34484689

Auteurs

Pascal Mutz (P)

National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20894.

Nash D Rochman (ND)

National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20894.

Yuri I Wolf (YI)

National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20894.

Guilhem Faure (G)

Broad Institute of MIT and Harvard, Cambridge, MA 02142.

Feng Zhang (F)

Broad Institute of MIT and Harvard, Cambridge, MA 02142.
HHMI, Massachusetts Institute of Technology, Cambridge, MA 02139.
McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.

Eugene V Koonin (EV)

National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20894.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH